what are the potential side effects of glp-1 drugs Long-term Success GLP-1s Hinges on More Than Just a Prescription GLP-1 nausea: How to handle

And another GLP-1 pill for weight loss is also on its way: Eli Lilly, maker of Zepbound and Mounjaro and a Novo Nordisk competitor, is developing a tablet called orforglipron, which is expected to receive FDA approval this spring.

At the systemic level, GLP-1 RAs improve insulin sensitivity in peripheral tissues (muscle, adipose), reduce circulating free fatty acid flux to the liver, suppress hypothalamic appetite circuits to promote weight loss, and lower systemic pro-inflammatory cytokines (TNF-, IL-1, IL-6), thereby reducing the hepatic inflammatory milieu indirectly [7,26,30]

Such conceptual expansionfrom single-hormone correction to multi-hormonal restorationunderscores the novelty and translational importance of this review

Am J Med Open

He said the company's entrance into the obesity market could "come with synergies" to other areas of its business, such as inflammation and aesthetics